Asset
SCY-635
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01290965 | phase1 | completed | 2007-04-01 | 2008-12-01 | Scynexis, Inc. | Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients |
| NCT01265511 | phase2 | completed | 2010-11-01 | 2011-10-01 | Scynexis, Inc. | Study of SCY-635, Pegasys and Copegus in Hepatitis C |
FDA applications (0)
This company has no applications containing this asset.